SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: E_K_S who wrote (30034)2/13/2008 3:37:32 PM
From: Wallace Rivers  Read Replies (3) | Respond to of 78774
 
OT:

Auction Rate Securities have been mentioned to a friend of mine as a possible alternative to a money market or CD investment. Has any one had any experience with these ar any knowledge of these?
I personally feel that there must be more risk if they provide higher than MM rates.
TIA, Wallace



To: E_K_S who wrote (30034)2/15/2008 11:15:33 AM
From: Jurgis Bekepuris  Read Replies (2) | Respond to of 78774
 
Can you tell me why Buffett's share is not disclosed in BRKA's 13F form? It's definitely not because it's too small... All I find while searching is 2006 articles of Buffett buying some Tesco, but I do not see anything in his 2007 13Fs. Did he sell it?

BTW, SWCEY position is not disclosed either, I am not sure why, though it might have been acquired after 12/31.

On the other news of Buffett buys, his most recent 13F was released today. It's somewhat underwhelming. Buffett bought KFT during 2007. However, I find it difficult to find value in KFT: margins low, ROE low, balance sheet looks like crap - although it should look that way, since Altria put a lot of debt on it. The only positive is that they are slowly slowly paying off debt. 38b of intangible assets, 7b debt, theoretical equity of 28b, but negative tangible assets. Oh well. Not very low PE, 3.7% dividend per Yahoo... Not sure I would want to follow Buffett.

Buffett also bought more KMX. Another one where I don't see great value. Low margins, cleanish balance sheet.

Finally, press is making a big thing of BRKA's GSK purchase. It is really funny, since the position is very very tiny. I will hold my own very tiny GSK position though and see what happens. :)